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Abstract
Ciliary neurotrophic factor (CNTF) has been shown to decrease food intake in mouse mod-
els of obesity and to improve insulin sensitivity. It is well known that tight regulation of glucose
metabolism is essential for successful gestational outcomes (e.g. fetal growth), and that abnormal
insulin resistance is associated with preeclampsia (PE). To investigate the possibility that CNTF
might be involved in the regulation of insulin resistance during pregnancy, circulating levels of
CNTF were assessed in non-pregnant, normal pregnant, postpartum, and pregnant women with
PE. Sera from healthy non-pregnant women (n10), pregnant women (n30:1st trimester;n10, 2nd
trimester n10;3rd trimester;n10), postpartum women (n10), and patients with PE (n11) were stud-
ied with Western blotting. Circulating CNTF was detected by Western blotting, and the levels of
CNTF in pregnant women were decreased as compared with those in non-pregnant women, and
tended to decrease as pregnancy progressed. A significant decrease was found in PE as compared
with normal pregnancy. Circulating CNTF might be associated with physiological and abnormal
insulin resistance during pregnancy.
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Ciliary neurotrophic factor (CNTF) has been shown to decrease food intake in mouse models of obesity 
and to improve insulin sensitivity.  It is well known that tight regulation of glucose metabolism is essen-
tial for successful gestational outcomes (e.g.  fetal growth),  and that abnormal insulin resistance is 
associated with preeclampsia (PE).  To investigate the possibility that CNTF might be involved in the 
regulation of insulin resistance during pregnancy,  circulating levels of CNTF were assessed in non-
pregnant,  normal pregnant,  postpartum,  and pregnant women with PE.  Sera from healthy non-
pregnant women (n＝10),  pregnant women (n＝30: 1st trimester; n＝10,  2nd trimester n＝10; 3rd 
trimester; n＝10),  postpartum women (n＝10),  and patients with PE (n＝11) were studied with 
Western blotting.  Circulating CNTF was detected by Western blotting,  and the levels of CNTF in 
pregnant women were decreased as compared with those in non-pregnant women,  and tended to 
decrease as pregnancy progressed.  A signiﬁcant decrease was found in PE as compared with normal 
pregnancy.  Circulating CNTF might be associated with physiological and abnormal insulin resistance 
during pregnancy.
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iliary neurotrophic factor (CNTF) is a 22-kDa 
cytokine belonging to the interleukin (IL)-6 
family [1,  2],  and is mainly expressed in glial cells 
within the central and peripheral nervous systems [3,  
4].  Barbin et al.  (1984) have described the neu-
rotrophic activity of CNTF puriﬁed from chick eye 
[5],  and ablation of CNTF gene by homologous 
recombination in mice (Masu et al.  (1993)) has shown 
that progressive atrophy and loss of motor neurons 
occurs in homozygotes [6].  In addition to functions in 
the central nervous system,  there have been several 
reports regarding the detection of circulating CNTF 
in healthy individuals,  patients with septic shock,  
systemic lupus erythematosus,  rheumatoid arthritis,  
multiple myeloma,  and amyotrophic lateral sclerosis 
[7-11]; however,  the physiological relevance of cir-
culating CNTF still needs to be established.  Recent 
studies have revealed that CNTF is able to bind to a 
speciﬁc receptor that is widely distributed throughout 
the body and that consists of CNTF-speciﬁc compo-
nents [1]: gp130 and leukemia inhibitory factor 
(LIFR) [1,  12,  13].  No report regarding circulating 
levels of CNTF in pregnancy has been published.  
Importantly,  exogenously administered CNTF has 
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been found to decrease food intake in mouse models of 
obesity and to improve peripheral insulin resistance by 
decreasing hepatic steatosis [14-19].
　 During pregnancy,  tight regulation of glucose 
metabolism is a prerequisite for appropriate fetal 
growth and for maternal well-being.  Insulin resistance 
in normal pregnancy,  which is considered to be 
“physiological, ” peaks at the third trimester and rap-
idly returns to pre-pregnancy levels after parturition.  
PE,  which occurs in approximately 5 to 10ｵ of all 
pregnant woman,  is one of the most common preg-
nancy-associated disorders [20],  and several lines of 
evidence suggest that insulin resistance is associated 
with PE [20,  21].  Our data indicate that circulating 
CNTF is decreased during pregnancy when physiolog-
ical insulin resistance is present,  and the levels of 
CNTF in PE were signiﬁcantly decreased as com-
pared with matched normal pregnancy.
Materials and Methods
　 Human subjects. Retrospectively and ran-
domly selected sera from 10 healthy women,  30 
healthy pregnant women without PE,  10 postpartum 
women,  and ten PE cases were analyzed for circulat-
ing CNTF levels.  PE was diagnosed and classiﬁed 
according to the technical bulletin of the American 
College of Obstetricians and Gynecologists and the 
National High Blood Pressure Education Program 
Working Group Report on High Blood Pressure in 
Pregnancy [22,  23].  Sera were separated immedi-
ately after the blood collection by centrifugation,  and 
were stored frozen at－20℃ until use.  Normal preg-
nant samples were collected from pregnant women at 
various gestational weeks at their regular visits,  and 
non-pregnant samples were obtained from volunteer 
women.  Postpartum samples were collected at 4 days 
after delivery.  In all but one PE case,  blood was col-
lected just prior to delivery.  From one particular PE 
case,  sera were collected at 2 diﬀerent times (at 
hospitalization and pre-operation (emergency cesarean 
section)).  At hospitalization,  the blood pressure of the 
patient was 160/100mmHg.  When we decided to 
perform a cesarean section due to non-reassuring fetal 
status,  the blood pressure of the patient was 
200/110mmHg.  All pregnant samples were collected 
before rupture of the membrane and the initiation of 
labor to avoid possible inﬂuence.
　 This study was approved by the Institutional 
Ethical Review Board of Okayama University 
Hospital (project # 186,  June 21th,  2004),  and all 
subjects provided informed consent.
　Western blotting. Western blotting of serum 
samples was performed as follows.  Sera were diluted 
at a 1 : 20 ratio with Phosphate-Buﬀered Saline 
(PBS),  mixed with 5x SDS-PAGE loading buﬀer,  
boiled for 5min,  and separated by 10-20ｵ SDS 
gradient polyacrylamide gels.  After the separation,  
proteins were electroblotted onto a nitrocellulose 
membrane (Hybond-C.  GE healthcare UK Ltd.,  
Buckinghamshire,  UK),  even-loading was conﬁrmed by 
Ponceau-S reversible staining,  and non-speciﬁc bind-
ing was blocked at room temperature for 2h with 5ｵ 
BSA.  Thereafter,  membranes were incubated at 4℃ 
overnight with chicken anti-human CNTF polyclonal 
antibody (1 : 2000,  Abcam Plc.,  Cambridge,  UK) in 
the blocking buﬀer.  The membranes were then washed 
and incubated for 2h at room temperature with 
1 : 10000 diluted horse radish peroxidase-conjugated 
donkey anti-chicken IgY (Jackson Immunoresearch 
Laboratories Inc.,  West Grove,  PA,  USA),  washed,  
and speciﬁc signals were visualized with Super signal® 
West pico Chemiluminescent Substrate (Pierce 
Biotechnology,  Inc.,  Rockford,  IL,  USA).  The sig-
nal intensities of the speciﬁc bands were densitomet-
rically analyzed with Scion image computer software 
(Scion Corp.,  Frederick,  MD,  USA).  The reference 
serum was prepared from a healthy non-pregnant 
woman and was loaded onto every blot; the signal 
intensity of each sample was compared with this refer-
ence,  then expressed as an arbitrary unit; sample/
standard ratio.  As a positive control,  recombinant 
human CNTF (Pepro Tech Inc.,  Rocky Hill,  NJ,  
USA) was used.
　 Statistical analysis. Statistical signiﬁcance 
was analyzed using Stat Mate III (Atms Co.,  Ltd.,  
Tokyo,  Japan).  For the analysis of 2 independent 
groups (e.g.  normal pregnant v.s.  PE),  Mann-Whitneyʼs 
U test and chi-square test were used.  For the analysis 
of CNTF levels at various gestational ages,  the 
Kruskal-Wallis test was used.  P-values less than 0.05 
are considered to be signiﬁcant.
Results
　 Characteristics of patients with PE and con-
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trol (normal pregnancy). Patient characteris-
tics were compared between PE and healthy pregnant 
women (Table 1).  No signiﬁcant diﬀerences were 
found for the average maternal age,  the percentage of 
primigravida,  height,  the percentage of smokers.  The 
blood pressure of PE at the time of blood sampling 
(176±4.92 / 107±3.78) was signiﬁcantly higher than 
that of normal pregnancy (104±2.86 / 46.2±2.45).  
Body weight and BMI before pregnancy,  body weight 
at the time of blood sampling for CNTF levels (gesta-
tional weeks: normal pregnancy; 31.9±0.70 (median 
32,  range 29-36),  PE; 31.7±0.90 (median 32,  range 
28-36),  not signiﬁcant,  and body weight at delivery of 
PE were signiﬁcantly heavier than that of normal 
pregnancy.  However,  body weight gain at the time of 
blood sampling and body weight gain at delivery of PE 
were signiﬁcantly smaller than that for normal preg-
nancy.  Gestational age at delivery and the birth 
weight of the newborns of PE (32.8±0.84 weeks,  
1,457±133 grams) were signiﬁcantly smaller than 
those of normal pregnancy (38.7±0.52 weeks,  3,240
±110 grams).
　 Detection of circulating CNTF in non-preg-
nant and pregnant women. We ﬁrst attempted 
to detect circulating CNTF by Western blotting using 
speciﬁc antibody in healthy non-pregnant women.  A 
discrete band at the expected molecular weight of 
22.7kDa was detected (Fig.  1A).  In addition,  several 
nonspeciﬁc bands were present.  Next,  in order to 
assess the inﬂuence of pregnancy on circulating CNTF 
levels,  sera from pregnant women were compared with 
non-pregnant controls.  CNTF was detected in both 
statuses.  Circulating levels of CNTF in pregnant 
women (gestational weeks: median 25,  range 10-39) 
were signiﬁcantly decreased as compared with non-
pregnant women (0.78±0.08 v.s.  0.56±0.04,  mean
±S. E. M. ) (Fig.  1B,  C).  To observe the eﬀect of 
gestational weeks,  circulating levels of CNTF were 
evaluated in each trimester.  The levels of circulating 
CNTF were signiﬁcantly decreased in the 2nd and 3rd 
trimesters as compared with the 1st trimester (1st 
trimester; 0.89±0.09,  2nd trimester; 0.66±0.06,  
3rd trimester 0.56±0.09,  mean±S. E. M. ) (Fig.  
2A,  B).  No signiﬁcant diﬀerence was seen between 
non-pregnant women and the 1st trimester (data not 
shown).  We also looked at the postpartum CNTF 
levels.  Circulating levels of CNTF remained low at 4 
days after delivery (Fig.  2A,  B).
　 Decreased circulating levels of CNTF in 
PE. We next assessed the levels of circulating 
CNTF in PE. PE samples were compared with gesta-
tional age-matched normal pregnant samples.  
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Table 1　 Characteristics of PE patients and healthy pregnant women
Normal Preg. (n＝9) PE (n＝10) P value
Age (years old) 31.8±0.73 (29,  20ﾝ40) 33.9±1.48 (34,  25ﾝ41) NS
Primigravida number (％) 3 (33) 5 (45) NS
Systolic blood pressure (mmHg) 104±2.86 (102,  94ﾝ120) 176±4.92 (181,  160ﾝ200) ＜0.01
Diastolic blood pressure (mmHg) 46.2±2.45 (50,  36ﾝ58) 107±3.78 (109,  96ﾝ142) ＜0.01
Height (cm) 162±2.27 (160,  150ﾝ170) 158±1.87 (160,  150ﾝ167) NS
Body weight (prepregnancy) (kg) 56.6±2.91 (56,  47ﾝ76) 65.0±5.21 (60,  44ﾝ95) ＜0.01
Body weight＊ (kg) 65.9±2.79 (65,  52ﾝ83) 71.2±4.33 (65,  55ﾝ99) ＜0.01
Body weight at delivery (kg) 66.1±2.70 (66,  55ﾝ83) 71.3±4.35 (65,  55ﾝ99) ＜0.01
Body weight gain＊ (kg) 9.25±1.11 (8.9,  5.4ﾝ14.8) 6.22±1.70 (7.6, ﾝ4.5ﾝ14) ＜0.01
Body weight gain at delivery (kg) 9.44±1.97 (11,  6ﾝ16) 6.24±1.83 (7.6, ﾝ4.5ﾝ14) ＜0.01
Smoking (％) 1 (11) 1 (9.1) NS
BMI (prepregnancy) 21.4±0.84 (21.4,  18.3ﾝ26.2) 25.8±1.84 (25.1,  19.6ﾝ37.1) ＜0.01
Gestational age＊ (weeks) 31.9±0.70 (32,  29ﾝ36) 31.7±0.90 (32,  28ﾝ36) NS
Gestational age at delivery (weeks) 38.7±0.52 (38,  37ﾝ41) 32.8±0.84 (32,  28ﾝ36) ＜0.01
Birth weight (gram)
3,240±110 1,457±133 ＜0.01
(3,140,  2,936ﾝ4,048) (1,288,  749ﾝ2,120)
Unless noted,  values are the mean±S. E. M (median,  range).  Normal Preg. ; gestational-age-matched healthy pregnant women.  PE,  
preeclampsia; BMI,  body mass index; NS,  not signiﬁcant. ＊ at the time of blood sampling for CNTF levels [Gestational weeks for normal 
pregnancy: 31.9 ±0.70 (median 32,  range 29ﾝ36),  for PE: 31.7 ±0.90 (32,  28ﾝ36)] Statistical analysis was conducted by Mann-
Whitneyʼs U test except for “primigravidanumber” and “smoking” which were conducted by chi-square test.
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Circulating levels of CNTF in PE cases were signiﬁ-
cantly lower than those in normal pregnant women 
(0.34±0.05 v.s.  0.18±0.01,  mean±S. E. M,  p＜
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Fig.  1　 Detection of circulating human CNTF by Western blot-
ting & circulating levels of CNTF were decreased during pregnancy.  
A,  CNTF protein was detected by Western blotting in human 
serum (non-pregnant healthy individual).  A recombinant human 
CNTF (rhCNTF) was used as a positive control; B,  Circulating 
levels of CNTF was assessed by Western blotting.  Sera from vari-
ous gestational stages were compared with non-pregnant samples.  
Signal intensities of non-pregnant group were higher than that of 
pregnant group.  Standard,  healthy 24 years old woman; Non-preg.,  
non-pregnant healthy women; 1st,  1st trimester; 2nd,  2nd 
trimester; 3rd,  3rd trimester; C,  Circulating levels of CNTF in 
pregnant women were signiﬁcantly decreased as compared with 
non-pregnant women.  Densitometric quantiﬁcation of the blots is 
shown.  Non-preg.,  non-pregnant healthy women; Preg,  pregnant 
healthy women from various gestational stages.  ＊p＜0.05.
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Fig.  2　 Circulating levels of CNTF was decreased as pregnancy 
progressed.  A,  Circulating levels of CNTF was assessed by 
Western blotting,  and grouped into each trimester.  CNTF levels 
appeared to be decreased toward later gestation.  Circulating levels 
of CNTF were remained at low levels 4days after delivery.  Stan-
dard,  healthy 24 years old woman; 1st,  1st trimester; 2nd,  2nd 
trimester; 3rd,  3rd trimester; B,  Signiﬁcant decrease of levels of 
CNTF between 1st and 2nd,  or 1st and 3rd trimester,  or 1st and 
postpartum.  Densitometric quantiﬁcation is shown.  ＊p＜0.05,  
＊＊p＜0.01.  NS,  not signiﬁcant.
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0.01) (Fig.  3A B).  In addition,  the samples that were 
loaded on lanes 5 and 9 were collected from the same 
patient at hospitalization (gestational week 26) and just 
prior to the emergency cesarean section (gestational 
week 28),  (Fig.  3A).  The level of CNTF in lane 9 
was obviously lower than that of lane 5,  indicating 
that CNTF levels might be inversely correlated with 
the severity of the condition (repeated by loading side 
by sides).
　 Correlation of circulating CNTF levels and 
body weight gain at the 3rd trimester. Obesity 
is known to be associated with insulin resistance and 
gestational hypertension; therefore,  the relation 
between circulating CNTF and body weight was stud-
ied.  No signiﬁcant correlation was found between 
circulating CNTF levels and BMI in non-pregnant 
women (r＝0.15,  not signiﬁcant) (Fig 4A).  Correlations 
between CNTF levels and body weight,  CNTF levels,  
and blood glucose levels also were not signiﬁcant (data 
no shown).  The body weight gain of normal pregnancy 
(non-pregnant to 3rd trimester),  however,  was sig-
niﬁcantly correlated with circulating levels of CNTF 
(r＝0.87,  p＜0.01) (Fig.  4B).  There was no signiﬁ-
cant correlation between CNTF levels and the body 
weight gain of PE cases (r＝0.24,  not signiﬁcant),  
(Fig.  4C).
Discussion
　 Recently,  several new key regulators of insulin 
sensitivity have been described,  including adipokines 
(e.g.  TNFα,  IL-6,  leptin,  adiponectin,  and resistin) 
[24,  25].  These adipokines regulate insulin resis-
tance [24,  25],  and it has been of great interest how 
these adipokines are associated with the pathogenesis 
of PE [26-31] and gestational diabetes mellitus [32,  
33] in relation to the regulation of insulin resistance 
during pregnancy.
　 CNTF is one of the newest potential humoral fac-
tors that regulate insulin sensitivity [14-19].  
Recombinant CNTF (CNTFAX15) function via the 
central and peripheral pathway results in anti-obe-
sogenic eﬀects and an improvement of insulin sensitiv-
ity [16,  19,  34-37]; CNTF is therefore believed to 
have 2 sites of action: the central nervous system and 
peripheral organs.  CNTF receptors localized on 
hypothalamic neurons are involved in feeding and 
weight control.  CNTF functions centrally via gp130 
receptor signaling in proopiomelanocortin (POMC)-
expressing neurons in the hypothalamus to reduce 
AMP-activated kinase (AMPK) activity [38].  In addi-
tion,  CNTF decreases feeding and weight by sup-
pressing neuropeptide Y (NPY) [34] and inducing 
133CNTF during PregnancyApril 2010
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Fig.  3　 Decreased circulating levels of CNTF in preeclampsia.  
A,  Circulating levels of CNTF was assessed by Western blotting.  
Circulating levels of CNTF in PE cases appeared to be decreased 
as compared with gestational-age-matched normal pregnant women.  
Standard,  healthy 24 years old woman; Normal Preg,  gestational-
age-matched normal pregnant women; PE, preeclampsia; B,  
Circulating levels of CNTF in PE cases were signiﬁcantly lower than 
healthy normal pregnant women.  Densitometric quantiﬁcation is 
shown.  Lane 5 (at hospitalization) and Lane 9 (at pre-operation for 
emergency cesarean section) were collected from the same patient.  
Note that the intensity of lane 9 was lower than that of lane 5.  ＊＊p
＜0.01.
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neurogenesis in the arcuate nuclei [16].  In peripheral 
organs such as skeletal muscle [35] and adipocytes 
[36],  CNTF elevates AMPK activity,  which results 
in increased fatty acid oxidation.  Furthermore,  
CNTF acts to decrease steatosis of the liver [19] and 
lipid build-up in skeletal muscle [35],  which results in 
improved insulin sensitivity.  It is therefore likely that 
CNTF is involved in the regulation of insulin resistance 
by both central and peripheral actions; accordingly,  it 
is also very likely that CNTF is involved in the regu-
lation of insulin resistance during pregnancy.  These 
ﬁndings led us to assess the circulating levels of 
CNTF during pregnancy.
　 Circulating levels of CNTF were decreased during 
pregnancy,  which is consistent with the idea that 
CNTF acts to improve insulin resistance,  as “physi-
ological insulin resistance” occurs during pregnancy.  
Also,  during pregnancy,  “hemodilution” could aﬀect 
the concentrations of circulating factors.  While it is 
possible that decreased CNTF levels in normal preg-
nancy are a result of “hemodilution, ” lowered circulat-
ing levels of CNTF could cause attenuated peripheral 
actions of CNTF and thus might act to decrease 
insulin sensitivity in pregnant women.  Although the 
evidence is insuﬃcient,  the possibility remains that 
synthesis or secretion of circulating CNTF might be 
altered during pregnancy.
　 We also found that circulating levels of CNTF in 
PE were signiﬁcantly lower than those in normal 
pregnancy.  It has been well accepted that “hemocon-
centration [37]” occurs in PE that should lead to 
increased concentrations of circulating factors.  
Decreased circulating levels of CNTF in PE,  there-
fore,  might be indicative of decreased production/
secretion of CNTF.  Interestingly,  we were able to 
assess sera from one PE case at 2 stages.  Circulating 
levels of CNTF lowered as the severity of PE 
increased,  supporting this idea.  To prove that the 
production or secretion of circulating CNTF is regu-
lated in some way during pregnancy,  we must clarify 
the source of circulating CNTF,  which remains 
unknown.
　 It is well known that excess body weight gain is 
often associated with insulin resistance and also with 
gestational hypertension [39].  Therefore,  the cor-
relation between circulating CNTF levels and body 
weight gain was studied.  In non-pregnant women,  
there was no signiﬁcant correlation between BMI and 
134 Acta Med.  Okayama　Vol.  64,  No.  2Akahori et al.
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Fig.  4　 Correlation of circulating CNTF levels and BMI or body 
weight gain.  A,  Correlation of circulating CNTF levels and BMI in 
non-pregnant women is shown.  No signiﬁcant correlation was found 
between circulating CNTF levels and BMI in non-pregnant women 
(r＝0.15,  not signiﬁcant).  BMI,  body mass index; B,  Correlation 
of circulating CNTF levels and body weight gain at 3rd trimester is 
shown.  Body weight gain (non-pregnant to 3rd trimester) was posi-
tively correlated with circulating levels of CNTF at 3rd trimester (r＝
0.87,  p＜0.01).  Body weight gain,  body weight before pregnancy-
body weight at 3rd trimester; C,  Correlation of circulating CNTF 
levels and body weight gain at 3rd trimester is shown in PE cases.  
No signiﬁcant correlation was found between circulating CNTF levels 
and body weight gain in PE cases (r＝0.24,  not signiﬁcant).
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CNTF levels were found.  Interestingly,  a signiﬁcant 
positive correlation was found between body weight 
gain during pregnancy (with no complication) and the 
levels of CNTF at the time of blood sampling.  In PE,  
however,  no signiﬁcant correlation between body 
weight gain and CNTF levels at the time of delivery 
was found (Fig.  4C).  Hypothesizing that there are 
mechanisms regulating insulin resistance during preg-
nancy,  factors that improve or deteriorate insulin 
resistance might be assumed.  Under this assumption,  
such mechanisms might be aﬀected in PE,  and CNTF 
could be a factor that improves insulin resistance during 
normal pregnancy.  On the other hand,  body weight 
gain in PE is smaller than that in normal pregnancy 
(6.24±1.83 vs 9.25±1.11,  p＜0.01,  Table 1).  It is 
possible that patients at high risk for PE are usually 
under strict nutritional control (e.g.  calorie and salt 
intake),  and thus body weight gain is restricted.  This 
phenomenon might be the cause of the decreased 
CNTF levels in the PE group; however,  comparing 
similar body weight gain cases between the 2 groups,  
the levels of CNTF in PE were signiﬁcantly lower 
than those in normal pregnancy (CNTF 0.37±0.08 
PE 0.19±0.03,  n＝6,  p＜0.05,  (range 7-16kg,  
body weight gain of control vs PE: 12.2±1.3 vs 10.1
±0.9,  not signiﬁcant)).  Thus,  CNTF levels might be 
closely associated with body weight gain during preg-
nancy,  the underlying mechanism of which might be 
diﬀerent from non-pregnant status.  To clarify this 
point,  however,  it will be necessary to increase the 
number of samples in future studies.  In addition,  
HOMA-IR was compared between PE and the control 
group,  and it was found to be not signiﬁcantly diﬀer-
ent (data not shown).
　 It is well known that the placenta secretes a num-
ber of important peptide hormones (e.g.  hPL,  hCG 
etc.),  and is easily accessed after delivery; it is there-
fore tempting to examine the expression of CNTF in 
the placenta.  Our preliminary studies have shown the 
expression of CNTF mRNA and protein by RT-PCR 
and Western blotting (data not shown).  In addition,  
immunohistochemical study of normal and PE placen-
tas indicated that immunoreactive CNTF is decreased 
in PE placentas (data not shown).  Clearly further 
studies are required,  but the placenta is interesting as 
a possible source of CNTF during pregnancy.
　 Taken together,  we believe that our study provides 
new and important information regarding the func-
tional signiﬁcance of circulating CNTF in the regula-
tion of insulin resistance during pregnancy,  which 
might shed new light on the extra-neural functions of 
CNTF.
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